Schonfeld Strategic Advisors’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-52,800
| Closed | -$622K | – | 1343 |
|
|
2019
Q2 | $622K | Sell |
52,800
-200,400
| -79% | -$2.36M | 0.02% | 575 |
|
|
2019
Q1 | $3.46M | Sell |
253,200
-118,500
| -32% | -$1.62M | 0.12% | 228 |
|
|
2018
Q4 | $3.81M | Buy |
371,700
+18,000
| +5% | +$185K | 0.15% | 195 |
|
|
2018
Q3 | $5.89M | Buy |
353,700
+276,700
| +359% | +$4.61M | 0.26% | 108 |
|
|
2018
Q2 | $1.22M | Sell |
77,000
-104,234
| -58% | -$1.65M | 0.07% | 361 |
|
|
2018
Q1 | $2.3M | Buy |
+181,234
| New | +$2.3M | 0.17% | 170 |
|
|
2017
Q3 | – | Sell |
-53,865
| Closed | -$617K | – | 830 |
|
|
2017
Q2 | $617K | Sell |
53,865
-21,135
| -28% | -$242K | 0.06% | 358 |
|
|
2017
Q1 | $1.56M | Buy |
+75,000
| New | +$1.56M | 0.16% | 182 |
|
|
2016
Q4 | – | Sell |
-9,321
| Closed | -$305K | – | 690 |
|
|
2016
Q3 | $305K | Buy |
9,321
+106
| +1% | +$3.47K | 0.05% | 314 |
|
|
2016
Q2 | $230K | Buy |
+9,215
| New | +$230K | 0.05% | 358 |
|